ASHEcon Presidential Address
ASHEcon Registration necessary to attend Presidential Address.
Mark V. Pauly, PhD
Mark V. Pauly currently holds the position of Bendheim Professor in the Department of Health Care Management at the Wharton School of the University of Pennsylvania. He received the Ph.D. in Economics from the University of Virginia. He is Professor of Health Care Management and Professor of Business Economics and Public Policy at the Wharton School, Professor of Medical Ethics and Health Policy at the Perelman School of Medicine, and Professor of Economics in the School of Arts and Sciences at the University of Pennsylvania. He is a former commissioner on the Physician Payment Review Commission and an active member of the Institute of Medicine. One of the nation’s leading health economists, he has made significant contributions to the fields of medical economics and health insurance. His classic study on the economics of moral hazard was the first to point out how health insurance coverage may affect patients’ use of medical services. Subsequent work, both theoretical and empirical, has explored the impact of conventional insurance coverage on preventive care, on outpatient care, and on prescription drug use in managed care. His interests in health policy deal with ways to reduce the number of uninsured through tax credits for public and private insurance, and appropriate design for Medicare in a budget-constrained environment. He is currently studying the impacts of health care reform and the Affordable Care Act. He has explored the influences that determine whether insurance coverage is available and, through several cost effectiveness studies, the influence of medical care and health practices on health outcomes and cost. Mark is a co-editor-in-chief of the International Journal of Health Economics and Management and an associate editor of the Journal of Risk and Uncertainty. He has served on Institute of Medicine panels on public accountability for health insurers under Medicare and on improving the financing of vaccines. He currently serves as President of the American Society of Health Economists (ASHEcon).